Diabetes mellitus and periodontal diseases

Current Diabetes Reports

Volumn 13, Issue 3, 2013, Pages 445-452

  Sima, Corneliu ^a,b   Glogauer, Michael ^a,b  

^a Matrix Dynamics Group   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Diabetes mellitus; Glycemic control; HbA1c; Inflammation; Periodontal diseases

Indexed keywords

ADVANCED GLYCATION END PRODUCT; C REACTIVE PROTEIN; DOXYCYCLINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GELATINASE B; GLUCOSE; HEMOGLOBIN A1C; INTERLEUKIN 1BETA; NEUTROPHIL COLLAGENASE; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BACTERIUM DETECTION; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; COMBINATION CHEMOTHERAPY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DOSE RESPONSE; GINGIVITIS; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; IMMUNOPATHOGENESIS; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; LEUKOCYTE ADHERENCE; LIPID ANALYSIS; LOW DRUG DOSE; MECHANICS; METABOLIC REGULATION; MICROVASCULARIZATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OSTEOLYSIS; PERIODONTAL DISEASE; PERIODONTAL THERAPY; PORPHYROMONAS GINGIVALIS; PREVALENCE; PREVENTIVE DENTISTRY; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; RISK REDUCTION; TREATMENT INDICATION; BIOLOGICAL MODEL; COMPLICATION; PERIODONTAL DISEASES;

DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; HUMANS; HYPERGLYCEMIA; MODELS, BIOLOGICAL; PERIODONTAL DISEASES; RISK FACTORS;

EID: 84877738536     PISSN: 15344827     EISSN: 15390829     Source Type: Journal    
DOI: 10.1007/s11892-013-0367-y     Document Type: Article

References (97)

1. Glavind L, Lund B, Loe H. The relationship between periodontal state and diabetes duration, insulin dosage and retinal changes. J Periodontol. 1968;39(6):341-7.
2. Belting CM, Hiniker JJ, Dummett CO. Influence of diabetes mellitus on the severity of periodontal disease. J Periodontol. 1964;35(11/12):476-80.
3. Löe H. Periodontal disease. The sixth complication of diabetes mellitus. Diabetes Care. 1993;16(1):329-34. (Pubitemid 23013872)
4. Califano JV, Research SATCAAOP. Position paper: periodontal diseases of children and adolescents. J Periodontol. 2003;74(11):1696-704. (Pubitemid 37540713)
5. Ranney RR. Discussion: pathogenesis of gingivitis. J Clin Periodontol. 1986;13(5):356-9.
6. Lang NP, Schätzle MA, Löe H. Gingivitis as a risk factor in periodontal disease. J Clin Periodontol. 2009;36:3-8.
7. Kantarci A, Van Dyke TE. Resolution of inflammation in periodontitis. J Periodontol. 2005;76(11-s):2168-74. (Pubitemid 41748967)
8. Van Dyke TE. Control of inflammation and periodontitis. Periodontol. 2007;45(1):158-66.
9. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977-86. (Pubitemid 23307905)
10. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998;352(9131):854-65. (Pubitemid 28416719)
11. UKDPS RG. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ. 1998;317(7160):703-13.
12. Mealey BL, Ocampo GL. Diabetes mellitus and periodontal disease. Periodontol. 2007;44(1):127-53.
13. Demmer RT, Desvarieux M, Holtfreter B, Jacobs DR, Wallaschofski H, Nauck M, et al. Periodontal Status and A1C Change: longitudinal results from the Study of Health in Pomerania (SHIP). Diabetes Care. 2010;33(5):1037-43.
14. Soskolne WA, Klinger A. The relationship between periodontal diseases and diabetes: an overview. Ann Periodontol. 2001;6(1):91-8.
15. Taylor G, Borgnakke W. Periodontal disease: associations with diabetes, glycemic control and complications. Oral Dis. 2008;14(3):191-203. (Pubitemid 351379717)
16. Taylor GW. Bidirectional interrelationships between diabetes and periodontal diseases: an epidemiologic perspective. Ann Periodontol. 2001;6(1):99-112.
17. Chávarry NG, Vettore MV, Sansone C. The relationship between diabetes mellitus and destructive periodontal disease: a meta-analysis. Oral Health Prev Dent. 2009;7:107-27. This study provides a comprehensive review and meta-analysis of the relationship between diabetes and periodontal disease.
18. Lalla E, Bin C, Lal S, Tucker S, Greenberg E, Goland RS, et al. Periodontal changes in children and adolescents with diabetes: a case-control study. Diabetes Care. 2006;29(2):295-9. (Pubitemid 44106507)
19. Lalla E, Cheng B, Lal S, Kaplan S, Softness B, Greenberg E, et al. Diabetes mellitus promotes periodontal destruction in children. J Clin Periodontol. 2007;34(4):294-8.
20. Mattout C, Bourgeois D, Bouchard P. Type 2 diabetes and periodontal indicators: epidemiology in France 2002-2003. J Periodont Res. 2006;41(4):253-8. (Pubitemid 44392293)
21. Novak KF, Taylor GW, Dawson DR, Ferguson JE, Novak MJ. Periodontitis and gestational diabetes mellitus: exploring the link in NHANES III. J Public Health Dent. 2006;66(3):163-8. (Pubitemid 44870198)
22. Sarelius IH. Macromolecule permeability of in situ and excised rodent skeletal muscle arterioles and venules. AJP: Heart Circ Physiol. 2005;290(1):H474-80.
23. Andriankaja OM, Barros SP, Moss K, Panagakos FS, DeVizio W, Beck JD, et al. Levels of serum interleukin (IL)-6 and gingival crevicular fluid of IL-1beta and prostaglandin E(2) among non-smoking subjects with gingivitis and type 2 diabetes. J Periodontol. 2009;80(2):307-16.
24. Salvi GE, Franco LM, Braun TM, Persson GAR, Lang NP, Giannobile WV. Pro-inflammatory biomarkers during experimental gingivitis in patients with type 1 diabetes mellitus: a proof-of-concept study. J Clin Periodontol. 2009;37(1):9-16. This is a proof-of concept study demonstrating a hyper-inflammatory response to subgingival biofilms in patients with diabetes.
25. Tsai C, Hayes C, Taylor GW. Glycemic control of type 2 diabetes and severe periodontal disease in the US adult population. Community Dent Oral Epidemiol. 2002;30(3):182-92.
26. Firatli E. The relationship between clinical periodontal status and insulin-dependent diabetes mellitus. Results after 5 years. J Periodontol. 1997;68(2):136-40. (Pubitemid 127518255)
27. Oliver RC, Tervonen T. Periodontitis and tooth loss: comparing diabetics with the general population. J Am Dent Assoc. 1993;124(12):71-6.
28. Novaes AB, Gutierrez FG, Novaes AB. Periodontal disease progression in type II non-insulin-dependent diabetes mellitus patients (NIDDM). Part I-Probing pocket depth and clinical attachment. Braz Dent J. 1996;7(2):65-73.
29. Seppälä B, Ainamo J. A site-by-site follow-up study on the effect of controlled versus poorly controlled insulin-dependent diabetes mellitus. J Clin Periodontol. 1994;21(3):161-5.
30. Botero JE, Yepes FL, Roldán N, Castrillón CA, Hincapie JP, Ochoa SP, et al. Tooth and periodontal clinical attachment loss are associated with hyperglycemia in patients with diabetes. J Periodontol. 2012;83(10):1245-50.
31. Costa FO, Miranda Cota LO, Pereira Lages EJ, Dutra Oliveira AMS, Oliveira PAD, Magalhães Cyrino R, et al. progression of periodontitis and tooth loss associated with glycemic control individuals under periodontal maintenance therapy: a 5-year follow-up study. J Periodontol. 2012. doi: 10.1902/jop.2012.120255
32. de Pommereau V, Dargent-Paré C, Robert JJ, Brion M. Periodontal status in insulin-dependent diabetic adolescents. J Clin Periodontol. 1992;19(9 Pt 1):628-32.
33. Bridges RB, Anderson JW, Saxe SR, Gregory K, Bridges SR. Periodontal status of diabetic and non-diabetic men: effects of smoking, glycemic control, and socioeconomic factors. J Periodontol. 1996;67:1185-92. (Pubitemid 126573166)
34. Sastrowijoto SH, Hillemans P, van Steenbergen TJ, Abraham-Inpijn L, de Graaff J. Periodontal condition and microbiology of healthy and diseased periodontal pockets in type 1 diabetes mellitus patients. J Clin Periodontol. 1989;16(5):316-22.
35. Cutler CW, Machen RL, Jotwani R, Iacopino AM. Heightened gingival inflammation and attachment loss in type 2 diabetics with hyperlipidemia. J Periodontol. 1999;70(11):1313-21.
36. Al-Zahrani MS, Bissada NF, Borawskit EA. Obesity and periodontal disease in young, middle-aged, and older adults. J Periodontol. 2003;74(5):610-5. (Pubitemid 36701374)
37. Genco RJ, Grossi SG, Ho A, Nishimura F, Murayama Y. A proposed model linking inflammation to obesity, diabetes, and periodontal infections. J Periodontol. 2005;76(11 Suppl):2075-84. (Pubitemid 41748956)
38. Nibali L, D'Aiuto F, Griffiths G, Patel K, Suvan J, Tonetti MS. Severe periodontitis is associated with systemic inflammation and a dysmetabolic status: a case-control study. J Clin Periodontol. 2007;34(11):931-7.
39. Grossi SG, Zambon JJ, Ho AW, Dunford RG, Machtei EE, Norderyd OM. Assessment of risk for periodontal disease. I. Risk indicators for attachment loss. J Periodontol. 1994;65(3):260-7.
40. Thorstensson H, Kuylenstierna J, Hugoson A. Medical status and complications in relation to periodontal disease experience in insulin-dependent diabetics. J Clin Periodontol. 1996;23(3 Pt 1):194-202. (Pubitemid 126731920)
41. Saremi A, Nelson RG, Tulloch-Reid M, Hanson RL, Sievers ML, Taylor GW. Periodontal disease and mortality in type 2 diabetes. Diabetes Care. 2005;28(1):27-32. (Pubitemid 40095778)
42. Shultis WA, Weil EJ, Looker HC, Curtis JM, Shlossman M, Genco RJ, et al. Effect of periodontitis on overt nephropathy and end-stage renal disease in type 2 diabetes. Diabetes Care. 2007;30(2):306-11. (Pubitemid 46198335)
43. Taylor GW, Burt BA, Becker MP, Genco RJ, Shlossman M, Knowler WC, et al. Severe periodontitis and risk for poor glycemic control in patients with non-insulin-dependent diabetes mellitus. J Periodontol. 1996;67(10 Suppl):1085-93. (Pubitemid 126613089)
44. Ide R, Hoshuyama T, Wilson D, Takahashi K, Higashi T. Periodontal disease and incident diabetes: a seven-year study. J Dent Res. 2011;90(1):41-6.
45. Demmer RT, Jacobs DR, Desvarieux M. Periodontal disease and incident type 2 diabetes: results from the First National Health and Nutrition Examination Survey and its epidemiologic follow-up study. Diabetes Care. 2008;31(7):1373-9.
46. Simpson TC, Needleman I, Wild SH, Moles DR, and Mills EJ. Treatment of periodontal disease for glycaemic control in people with diabetes. Cochrane Database Syst Rev. 2010;(5):CD004714
47. Grossi SG, Skrepcinski FB, DeCaro T, Robertson DC, Ho AW, Dunford RG, et al. Treatment of periodontal disease in diabetics reduces glycated hemoglobin. J Periodontol. 1997;68(8):713-9. (Pubitemid 27357899)
48. Katagiri S, Nitta H, Nagasawa T, Uchimura I, Izumiyama H, Inagaki K, et al. Multi-center intervention study on glycohemoglobin (HbA1c) and serum, high-sensitivity CRP (hs-CRP) after local anti-infectious periodontal treatment in type 2 diabetic patients with periodontal disease. Diabetes Res Clin Pract. 2009;83(3):308-15.
49. Correa FOB, GonÃalves D, Figueredo CMS, Bastos AS, Gustafsson A, Orrico SRP. Effect of periodontal treatment on metabolic control, systemic inflammation and cytokines in patients with type 2 diabetes. J Clin Periodontol. 2010;37(1):53-8.
50. O'Connell PAA, Taba M, Nomizo A, Freitas MCF, Suaid FA, Uyemura SA, et al. Effects of periodontal therapy on glycemic control and inflammatory markers. J Periodontol. 2008;79(5):774-83.
51. Sun W-L, Chen L-L, Zhang S-Z, Ren YZ, Qin GM. Changes of adiponectin and inflammatory cytokines after periodontal intervention in type 2 diabetes patients with periodontitis. Arch Oral Biol. 2010;55(12):970-4.
52. Makiura N, Ojima M, Kou Y, Furuta N, Okahashi N, Shizukuishi S. Relationship of Porphyromonas gingivalis with glycemic level in patients with type 2 diabetes following periodontal treatment. Oral Microbiol Immunol. 2008;23(4):348-51. (Pubitemid 351832173)
53. Teeuw WJ, Gerdes VEA, Loos BG. Effect of periodontal treatment on glycemic control of diabetic patients: a systematic review and meta-analysis. Diabetes Care. 2010;33(2):421-7.
54. Kiran M, Arpak N, Unsal E, Erdoǧan MF. The effect of improved periodontal health on metabolic control in type 2 diabetes mellitus. J Clin Periodontol. 2005;32(3):266-72. (Pubitemid 40462659)
55. Jones JA, Miller DR, Wehler CJ, Rich SE, Krall-Kaye EA, McCoy LC, et al. Does periodontal care improve glycemic control? The Department of Veterans Affairs Dental Diabetes Study. J Clin Periodontol. 2007;34(1):46-52. This is a short-term multi-site, single blinded RCT with two-by-two design evaluating glycemic control after a single course of periodontal therapy in patients with poorly controlled diabetes mellitus and periodontitis. (Pubitemid 44952518)
56. Rocha M, Nava LE, Vázquez dela Torre C, Sánchez- Márin F, Garay-Sevilla ME, Malacara JM. Clinical and radiological improvement of periodontal disease in patients with type 2 diabetes mellitus treated with alendronate: a randomized, placebo-controlled trial. J Periodontol. 2001;7(2):204-9.
57. Al-Mubarak S, Ciancio S, Aljada A, Ross C, Dandona P. Comparative evaluation of adjunctive oral irrigation in diabetics. J Clin Periodontol. 2002;29(4):295-300. (Pubitemid 41697840)
58. Rodrigues DC, Taba MJ, Novaes ABJ, Souza SLS, Grisi MFM. Effect of non-surgical periodontal therapy on glycemic control in patients with type 2 diabetes mellitus. J Periodontol. 2003;74(9):1361-7. (Pubitemid 37336748)
59. Stewart JE, Wager KA, Friedlander AH, Zadeh HH. The effect of periodontal treatment on glycemic control in patients with type 2 diabetes mellitus. J Clin Periodontol. 2001;28(4):306-10. (Pubitemid 33761339)
60. Promsudthi A, Pimapansri S, Deerochanawong C, Kanchanavasita W. The effect of periodontal therapy on uncontrolled type 2 diabetes mellitus in older subjects. Oral Dis. 2005;11(5):293-8. (Pubitemid 41725939)
61. Darré L, Vergnes J-N, Gourdy P, Sixou M. Efficacy of periodontal treatment on glycaemic control in diabetic patients: A meta-analysis of interventional studies. Diabetes Metab. 2008;34(5):497-506.
62. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321(7258):405-12. (Pubitemid 30609442)
63. Khaw K-T, Wareham N, Bingham S, Luben R, Welch A, Day N. Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk. Ann Intern Med. 2004;141(6):413-20.
64. Mealey BL, Rose LF. Diabetes mellitus and inflammatory periodontal diseases. Curr Opin Endocrinol, Diabetes Obes. 2008;15(2):135-41. (Pubitemid 351651726)
65. Mealey BL, Oates TW, American Academy of Periodontology. Diabetes mellitus and periodontal diseases. J Periodontol. 2006;77(8):1289-303. (Pubitemid 44740584)
66. Manouchehr-Pour M, Spagnuolo PJ, Rodman HM, Bissada NF. Impaired neutrophil chemotaxis in diabetic patients with severe periodontitis. J Dent Res. 1981;60(3):729-30. (Pubitemid 11114931)
67. McMullen JA, Van Dyke TE, Horoszewicz HU, Genco RJ. Neutrophil chemotaxis in individuals with advanced periodontal disease and a genetic predisposition to diabetes mellitus. J Periodontol. 1981;52(4):167-73. (Pubitemid 11077936)
68. Graves DT, Liu R, Alikhani M, Al-Mashat H, Trackman PC. Diabetes-enhanced inflammation and apoptosis-impact on periodontal pathology. J Dent Res. 2005;85(1):15-21.
69. Salvi GE, Collins JG, Yalda B, et al. Monocytic TNF alpha secretion patterns in IDDM patients with periodontal diseases. J Clin Periodontol. 1997;24(1):8-16. (Pubitemid 127731485)
70. Kjersem H, Hilsted J, Madsbad S, Arnold RR, Lang NP, Offenbacher S. Polymorphonuclear leucocyte dysfunction during short term metabolic changes from normo- to hyperglycemia in type 1 (insulin dependent) diabetic patients. Infection. 1988;16(4):215-21.
71. Gustke CJ, Stein SH, Hart TC, Hoffman WH, Hanes PJ, Russell CM, et al. HLA-DR alleles are associated with IDDM, but not with impaired neutrophil chemotaxis in IDDM. J Dent Res. 1998;77(7):1497-503. (Pubitemid 32770521)
72. Gyurko R, Siqueira CC, Caldon N, Caldon N, Gao L, Kantarci A, et al. Chronic hyperglycemia predisposes to exaggerated inflammatory response and leukocyte dysfunction in Akita mice. J Immunol (Baltimore, Md: 1950). 2006;177(10):7250-6. (Pubitemid 44715094)
73. Sima C, Rhourida K, Van Dyke TE, Gyurko R. Type 1 diabetes predisposes to enhanced gingival leukocyte margination and macromolecule extravasation in vivo. J Periodont Res. 2010;45(6):748-56.
74. Beam HA, Parsons JR, Lin SS. The effects of blood glucose control upon fracture healing in the BB Wistar rat with diabetes mellitus. J Orthop Res. 2002;20(6):1210-6. (Pubitemid 35363979)
75. He H, Liu R, Desta T, Leone C, Gerstenfeld LC, Graves DT. Diabetes causes decreased osteoclastogenesis, reduced bone formation, and enhanced apoptosis of osteoblastic cells in bacteria stimulated bone loss. Endocrinology. 2004;145(1):447-52. (Pubitemid 38094541)
76. Liu R, Bal HS, Desta T, Krothapalli N, Alyassi M, Luan Q, et al. Diabetes enhances periodontal bone loss through enhanced resorption and diminished bone formation. J Dent Res. 2006;85(6):510-4. (Pubitemid 43945487)
77. Lalla E, Lamster IB, Feit M, Huang L, Spessot A, Qu W, et al. Blockade of RAGE suppresses periodontitis-associated bone loss in diabetic mice. J Clin Investig. 2000;105(8):1117-24. (Pubitemid 30217696)
78. Takeda M, Ojima M, Yoshioka H, Inaba H, Kogo M, Shizukuishi S, et al. Relationship of serum advanced glycation end products with deterioration of periodontitis in type 2 diabetes patients. J Periodontol. 2005;77(1):15-20.
79. Zizzi A, Tirabassi G, Aspriello SD, Piemontese M, Rubini C, Lucarini G. Gingival advanced glycation end-products in diabetes mellitus-associated chronic periodontitis: an immunohistochemical study. J Periodont Res. doi: 10.1111/jre.12007. Ref. 79 was not cited anywhere in the text. Please provide a citation. Alternatively, delete the item from the list.
80. Murillo J, Wang Y, Xu X, Klebe RJ, Chen Z, Zardeneta G, et al. Advanced glycation of type I collagen and fibronectin modifies periodontal cell behavior. J Periodontol. 2008;79(11):2190-9.
81. Lalla E, Kaplan S, Yang J, Yang J, Roth GA, Papapanou PN, et al. Effects of periodontal therapy on serum C-reactive protein, sE-selectin, and tumor necrosis factor-α secretion by peripheral blood-derived macrophages in diabetes. J Periodont Res. 2007;42(3):274-82.
82. Tonetti MS, D'Aiuto F, Nibali L, Donald A, Storry C, Parkar M, et al. Treatment of periodontitis and endothelial function. N Engl J Med. 2007;356(9):911-20. This is a single blinded RCT that evaluated the effects of non-surgical periodontal treatment on markers of endothelial dysfunction in patients with periodontits. (Pubitemid 46339910)
83. Engebretson S, Chertog R, Nichols A, Hey-Hadavi J, Celenti R, Grbic J. Plasma levels of tumour necrosis factor-alpha in patients with chronic periodontitis and type 2 diabetes. J Clin Periodontol. 2007;34(1):18-24. (Pubitemid 44952514)
84. Davé S, Van Dyke T. The link between periodontal disease and cardiovascular disease is probably inflammation. Oral Dis. 2008;14(2):95-101. (Pubitemid 351301054)
85. Beck J, Garcia R, Heiss G, Vokonas PS, Offenbacher S. Periodontal disease and cardiovascular disease. J Periodontol. 1996;67(10 Suppl):1123-37. (Pubitemid 126613093)
86. Friedewald VE, Kornman KS, Beck JD, Genco R, Goldfine A, Libby P, et al. The American Journal of Cardiology and Journal of Periodontology editors' consensus: periodontitis and atherosclerotic cardiovascular disease. J Periodontol. 2009;80(7):1021-32.
87. Loos BG. Systemic markers of inflammation in periodontitis. J Periodontol. 2005;76(11 Suppl):2106-15. (Pubitemid 41748960)
88. Noack B, Genco RJ, Trevisan M, Grossi S, Zambon JJ, De Nardin E. Periodontal infections contribute to elevated systemic C-reactive protein level. J Periodontol. 2001;72(9):1221-7. (Pubitemid 33607184)
89. Okabe K, Nakagawa K, Yamamoto E. Factors affecting the occurrence of bacteremia associated with tooth extraction. Int J Oral Maxillofac Surg. 1995;24(3):239-42.
90. Yoshii S, Tsuboi S, Morita I, Takami Y, Adachi K, Inukai J, et al. Temporal association of elevated C-reactive protein and periodontal disease in men. J Periodontol. 2009;80(5):734-9.
91. Nakano K, Nemoto H, Nomura R, Inaba H, Yoshioka H, Taniguchi K, et al. Detection of oral bacteria in cardiovascular specimens. Oral Microbiol Immunol. 2009;24(1):64-8.
92. Koren O, Spor A, Felin J, Fåk F, Stombaugh J, Tremaroli V, et al. Human oral, gut, and plaque microbiota in patients with atherosclerosis. Proc Natl Acad Sci. 2011;108 Suppl 1:4592-8.
93. Haraszthy VI, Zambon JJ, Trevisan M, Zeid M, Genco RJ. Identification of periodontal pathogens in atheromatous plaques. J Periodontol. 2000;71(10):1554-60.
94. Toyofuku T, Inoue Y, Kurihara N, Kudo T, Jibiki M, Sugano N, et al. Differential detection rate of periodontopathic bacteria in atherosclerosis. Surg Today. 2011;41(10):1395-400.
95. Desvarieux M. Periodontal microbiota and carotid intima-media thickness: the oral Infections and Vascular Disease Epidemiology Study (INVEST). Circulation. 2005;111(5):576-82. INVEST is randomly sampled population-based cohort study investigating the relationship between oral infections, carotid atherosclerosis, and stroke. The present study demonstrates a direct relationship between periodontal microbiology and subclinical atherosclerosis. (Pubitemid 40216484)
96. Desvarieux M, Demmer RT, Jacobs DR, Rundek T, Boden-Albala B, Sacco RL, et al. Periodontal bacteria and hypertension: the oral infections and vascular disease epidemiology study (INVEST). J Hypertens. 2010;28(7):1413-21. INVEST is randomly sampled population-based cohort study investigating the relationship between oral infections, carotid atherosclerosis, and stroke. The present study demonstrates a direct relationship between levels of subgingival bacterial levels and systolic, diastolic blood pressure and prevalence of hypertension.
97. Sima C, Glogauer M. Periodontitis in patients with diabetes - a complication that impacts on metabolic control. US Endocrinol. 2012;8:35-9.